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White adipose tissue urea cycle activity is
not aﬀected by one-month treatment with
a hyperlipidic diet in female rats†
Sofía Arriarán,a Silvia Agnelli,a Xavier Remesar,a,b,c Marià Alemanya,b,c and
José Antonio Fernández-López*a,b,c
Under high-energy diets, amino acid N is diﬃcult to dispose of, as a consequence of the availability of
alternative substrates. We found, recently, that WAT contains a complete functional urea cycle, we ana-
lyzed the possible overall changes in the WAT urea cycle (and other-related amino acid metabolism gene
expressions) in rats subjected to a cafeteria diet. Adult female Wistar rats were fed control or simpliﬁed
cafeteria diets. Samples of WAT sites: mesenteric, periovaric, retroperitoneal and subcutaneous, were
used for the estimation of all urea cycle enzyme activities and gene expressions. Other key amino acid
metabolism gene expressions, and lactate dehydrogenase were also measured. Subcutaneous WAT
showed a diﬀerentiated amino acid metabolism proﬁle, since its cumulative (whole site) activity for most
enzymes was higher than the activities of the other sites studied. After one month of eating an energy-
rich cafeteria diet, and in spite of doubling the size of WAT, the transforming capacity of most amino acid
metabolism enzymes remained practically unchanged in the tissue. This was not only due to limited
changes in the overall enzyme activity, but also a consequence of a relative decrease in the expression of
the corresponding genes. Overall, the results of this study support the consideration of WAT as an organ,
disperse but under uniform control. The metabolic peculiarities between its diﬀerent sites, and their
ability to adapt to diﬀerent energy availability conditions only add to the variable nature of adipose tissue.
We have presented additional evidence of the signiﬁcant role of WAT in amino acid metabolism.
Introduction
The most characteristic trait of white adipose tissue (WAT) is
its inordinate growth when experiment animals are exposed
to energy-rich, mainly hyperlipidic, diets such as the self-
selected “cafeteria” diets.1,2 These diets are widely used as a
model of human obesity, largely attributed to the consumption
of high-energy/hyperlipidic diets,1,3 which elicit the develop-
ment of inflammation.4 Inordinate WAT growth has been
intensely studied, along with the development of other patho-
logies related to inflammation in the context of metabolic syn-
drome.5,6 Inflamed WAT reacts to the ‘aggression’ of excess
nutrient availability by reducing its blood flow7 to diminish
that availability and lower its storage of fat. In that process,
WAT also releases a number of adipokines,8 which tend to
help activate the defense systems and metabolic adaptations to
face oﬀ the problem of disposal of excess available energy.9
The key point is the massive glucose-fueled lipogenesis,
since the WAT insulin response is better maintained, under
conditions of generalized insulin resistance, than in other
peripheral organs and the liver.10 Thus, the adipocyte could
not fully prevent the uptake of high circulating glucose other
than decreasing blood flow,7 which may elicit hypoxia,11 and
lower the synthesis of acyl-glycerols. We have found recently
that both cultured 3T3-L1 adipocytes,12 and rat WAT in vivo,13
break up inordinate amounts of glucose to release 3C units,
largely lactate.12–14 This is a consequence of the diversion of
pyruvate towards lactate instead of entering the mitochondria
and producing acetyl-CoA, the key building block of acyl-CoA.
Reduced oxidative metabolism facilitates the process; in vivo
studies in humans and rats have shown low oxygen levels in
WAT without signs of hypoxia.15,16 This “normal hypoxia” is
linked to low WAT oxygen consumption in vivo.16 Evidently,
these data contrast with the obvious hypertrophic and hyper-
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plasic growth of WAT when the adipocyte is exposed to abun-
dant glucose. Curiously, in cultured adipocytes, diﬀerentiation
from fibroblast and massive accumulation of fat, at high
medium glucose levels, is continued by a massive breakup to
lactate of this same glucose when the cells are mature and
their fat stores are large.13 Therefore, lipogenesis and the
potential resistance to hypoxia run in parallel, i.e. the hyper-
trophic WAT response to excess glucose and oxygen needs
should be markedly diﬀerent from a basal or cell energy-
starved state, when lipogenesis is highly stimulated.
Amino acid metabolism is not generally included in overall
energy metabolism analyses, in part because of its complexity,
usually limited provision of energy, and its direct implication
with a number of biosynthetic paths, of which protein syn-
thesis is paramount for survival. However, all cells have a sig-
nificant amino acid metabolism, despite the central role of
liver and other organs of the splanchnic bed,17,18 since they
play the double role of controlling the dietary supply of amino
acids and are the main site for the final conversion of 2-amino
N to ammonium, and finally urea.
The mechanisms of preservation of 2-amino N have evolved
to powerful fail-safe mechanisms, which prevent the loss of
hard-to-obtain amino acids.19,20 However, high-energy high-
quality protein diets tend to create havoc in the mechanisms
of regulation of amino acid metabolism: cafeteria diets
decrease the excretion of urea N in spite of maintained (or
increased) N intake;21 the form of excretion of excess N –
which could not be stored in significant amounts—is
unknown.22,23 In this context the role of WAT is, usually, not
even considered, in part because of the wrongly perceived low
global metabolic activity of the tissue and our superficial
knowledge of amino acid metabolism in WAT.24 We have
found, recently, that WAT contains a complete and functional
urea cycle,25 which makes our assumptions of how 2-amino N
is disposed of even more complicated, especially under con-
ditions of obesity/inflammation, since an increase in the WAT
mass could result in a parallel increase in its ability to dispose
of 2-amino N. In the present study, we have analyzed in detail
the possible overall changes in the WAT urea cycle (and other-
related amino acid metabolism gene expressions) in female
rats subjected to a cafeteria diet compared with controls. The
comparisons have been done essentially by comparing the
whole WAT site enzyme activity (or gene expression) of control
and cafeteria diet-fed rats to better understand their possible
influence on the whole body amino acid handling capability.
Materials and methods
Experimental design and animal handling
All animal handling procedures and the experimental setup
were in accordance with the animal handling guidelines of the
corresponding European and Catalan Authorities. The Com-
mittee on Animal Experimentation of the University of Barce-
lona specifically authorized the procedures used in the present
study.
Nine week old female Wistar rats (Harlan Laboratory
Models, Sant Feliu de Codines, Spain) were used. Six animals
per group were housed in two-rat cages and had free access to
water. The animals were kept in a controlled environment
(lights on from 08:00 to 20:00; 21.5–22.5 °C; 50–60% humid-
ity). Two groups were randomly selected and were fed
ad libitum, for 30 days, with either normal rat chow (#2014,
Harlan) or a simplified cafeteria diet:26 chow pellets, plain
cookies, with liver pâté, bacon, whole milk containing 300 g
per L sucrose and a mineral and vitamin supplement. We used
the procedures for food intake estimation and analysis pre-
viously described.27 The estimated diet intake composition
was (expressed as energy content): carbohydrate 67%, protein
20%, and lipid 13% for controls. That of rats fed the cafeteria
diet (i.e. food ingested during the 30 d period studied) was:
carbohydrate 47%, protein 12% and lipid 41% (energy
content). This diet induced a significant increase in body fat,
and it has been used for a long time in studies on metabolic
syndrome.26,28
The rats were killed, under isoflurane anesthesia, at the
beginning of a light cycle by aortic exsanguination, using dry-
heparinized syringes; then, were rapidly dissected, taking
samples of WAT sites: mesenteric (ME), periovaric (PO), retro-
peritoneal (RP) and subcutaneous (SC, inguinal fat pads). The
samples were blotted, and frozen with liquid nitrogen. After
weighing, they were ground under liquid nitrogen; sample ali-
quots were stored at −80 °C until processed. Later, the dissec-
tion of the rats continued, extracting the remaining WAT in
ME, EP and RP sites; the rats were skinned, and the whole sub-
cutaneous WAT was dissected. The weights of the recovered
WAT were added to obtain the total mass of each WAT site.
Blood plasma parameters
The blood obtained from the aorta puncture was centrifuged
to obtain plasma, which was frozen and kept at −80 °C until
processed. Plasma samples were used to measure glucose (kit
#11504), triacylglycerols (kit #11828), total cholesterol (kit
#11505) and urea (kit # 11537), all from Biosystems, Barcelona
Spain). Lactate was measured with kit #1001330 (Spinreac,
Sant Esteve de Bas, Spain). Amino acids were analyzed indivi-
dually with an amino acid analyzer (Pharmacia-LKB-Alpha-
plus, Uppsala, Sweden) using plasma samples deproteinized
with acetone.29 Since the method used did not provide fair
analyses for glutamine and other amino acids (Trp, Cys, Asn),
we decided to present only the partial sum of the other amino
acids as a single indicative value.
Preparation of tissue homogenates
Frozen tissue samples were homogenized, using a tissue dis-
ruptor (Ultraturrax IKA-T10, Ika Werke, Staufen, Germany), in
5 volumes of chilled 70 mM hepes buﬀer pH 7.4 containing
1 mM dithiothreitol (Sigma-Aldrich, St Louis MO, USA),
50 mM KCl, 1 g per L Triton X-100 (Sigma) and 1 g per L lipid-
free bovine serum albumin (Sigma-Aldrich). In homogenates
to be used for carbamoyl-P synthase 2 estimation, the
concentration of Triton X-100 was reduced to 0.5 g per L to
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decrease foaming. The homogenates were centrifuged for
10 min at 5000g; the floating fat layers and debris precipitates
were discarded. The clean homogenates were kept on ice, and
used for enzyme analyses within 2 h.
Tissue protein was estimated with the Lowry method,30
using finely powdered inert MgO to eliminate the remaining
fat-generated turbidity after development of color. Homogeniz-
ation buﬀer (which contained albumin) was used as blank.
Enzyme activities were initially expressed in nkat per g protein.
Enzyme activity analyses
Carbamoyl-P synthase was estimated from the incorporation of
14C-bicarbonate (Perkin Elmer, Bad Neuheim, Germany) into
carbamoyl-P using a method previously described by us.31
All other urea cycle enzyme activities (ornithine carbamoyl-
transferase, arginino-succinate synthase, arginino-succinate
lyase and arginase) were estimated following our recently
developed methods which are presented with detail in the
Methods, ESI.†
A modified UV method was used for lactate dehydrogenase
activity.32 The reaction mixture contained 150 µM NADH,
125 mg per L bovine serum albumin and 1 mM sodium pyru-
vate (Sigma-Aldrich). The proportion of original tissue in each
measuring well was in the range of 2.0–2.5 mg, in a volume of
0.02 mL of homogenate, diluted to the adequate proportions
with homogenization medium. Absorbance at 340 nm was
measured at intervals of 30 s for up to 10 min. In each case,
the decrease in absorbance, due to the formation of NAD+, was
plotted, and initial (V0) activities were determined from the
course of the reaction at diﬀerent times.
Gene expression analysis
Total tissue RNA was extracted from frozen tissue samples
using the Tripure reagent (Roche Applied Science, Indiana-
polis IN, USA), and was quantified in an ND-100 spectro-
photometer (Nanodrop Technologies, Wilmington DE, USA). RNA
samples were reverse transcribed using the MMLV reverse tran-
scriptase (Promega, Madison, WI, USA) system and oligo-dT
primers. These data were also used to determine the total RNA
content of the tissue (expressed per g of tissue weight).
Real-time PCR (RT-PCR) amplification was carried out
using 10 μL amplification mixtures containing Power SYBR
Green PCR Master Mix (Applied Biosystems, Foster City, CA,
USA), 4 ng of reverse-transcribed RNA and 150 nanomols of
primers. Reactions were run on an ABI PRISM 7900 HT detec-
tion system (Applied Biosystems) using a fluorescent threshold
manually set to 0.15 for all runs.
A semi-quantitative approach for the estimation of the con-
centration of specific gene mRNAs per unit of tissue/RNA or
protein weight was used.33 Rplp0 was the charge control
gene.34 We expressed the data as the number of transcript
copies per gram of protein in order to obtain comparable data
between the groups. The genes analyzed and a list of primers
used is presented in Table 1.
Statistics
One- and two-way ANOVA comparisons between groups and
curve fitting (e.g. for Vi estimations) were analyzed with the
Prism 5 program (GraphPad Software, San Diego, CA, USA).
Results
Fig. 1 shows that the rat weight changes within 30 days of
feeding the cafeteria or control diets. Rats fed cafeteria diet
gained more body weight and ended up weighing more than
control animals. Table 2 shows the weights of the four WAT
sites studied, as well as the levels of protein and RNA per g of
Table 1 Primer sequences used in the analysis of WAT gene expressions
Gene Protein EC Primer sequence 5′ > 3′ Primer sequence 3′ > 5′ bp
Cad Glutamine-dependent carbamoyl-phosphate synthase 6.3.5.5 AGTTGGAGGAGGAGGCTGAG ATTGATGGACAGGTGCTGGT 90
Otc Ornithine carbamoyl transferase 2.1.3.3 CTTGGGCGTGAATGAAAGTC ATTGGGATGGTTGCTTCCT 126
Ass1 Arginino-succinate synthase 6.3.4.5 CAAAGATGGCACTACCCACA GTTCTCCACGATGTCAATGC 100
Asl Arginino-succinate lyase 4.3.2.1 CCGACCTTGCCTACTACCTG GAGAGCCACCCCTTTCATCT 104
Arg1 Arginase-1 3.5.3.1 GCAGAGACCCAGAAGAATGG GTGAGCATCCACCCAAATG 126
Arg2 Arginase-2 3.5.3.1 GCAGCCTCTTTCCTTTCTCA CCACATCTCGTAAGCCAATG 122
Nags N-Acetyl-glutamate synthase 2.3.1.1 GCAGCCCACCAAAATCAT CAGGTTCACATTGCTCAGGA 82
Nos3 Nitric oxide synthase, endothelial 1.14.13.39 CAAGTCCTCACCGCCTTTT GACATCACCGCAGACAAACA 138
Glul Glutamine synthetase 6.3.1.2 AACCCTCACGCCAGCATA CTGCGATGTTTTCCTCTCG 148
Gls Glutaminase kidney isoform, mitochondrial 3.5.1.2 CCGAAGGTTTGCTCTGTCA AGGGCTGTTCTGGAGTCGTA 63
Glud1 Glutamate dehydrogenase 1, mitochondrial 1.4.1.3 GGACAGAATATCGGGTGCAT TCAGGTCCAATCCCAGGTTA 122
Gcsh Glycine cleavage system H protein, mitochondrial — AAGCACGAATGGGTAACAGC TCCAAAGCACCAAACTCCTC 146
Ampd2 AMP deaminase 2 3.5.4.6 CGGCTTCTCTCACAAGGTG CGGATGTCGTTACCCTCAG 78
Gpt Alanine aminotransferase 1 2.6.1.2 GTATTCCACGCAGCAGGAG CACATAGCCACCACGAAACC 85
Gpt2 Alanine aminotransferase 2 2.6.1.2 CATTCCCTCGGATTCTCATC GCCTTCTCGCTGTCCAAA 146
Bcat1 Branched-chain-amino-acid aminotransferase,
cytosolic
2.6.1.42 TGCCCAGTTGCCAGTATTC CAGTGTCCATTCGCTCTTGA 138
Bcat2 Branched-chain-amino-acid aminotransferase,
mitochondrial
2.6.1.42 AGTCTTCGGCTCAGGCACT ATGGTAGGAATGTGGAGTTGCT 84
Ldha Lactic acid dehydrogenase muscle type (a) 1.1.1.27 CACTGGGTTTGAGACGATGA GTCAGCAAGAGGGAGAGAGC 125
Ldhb Lactic acid dehydrogenase heart type (b) 1.1.1.27 CCAGGAACTGAACCCAGAGA TCATAGGCACTGTCCACCAC 131
Rplp0 60S acidic ribosomal protein 0 (housekeeping gene) — GAGCCAGCGAAGCCACACT GATCAGCCCGAAGGAGAAGG 62
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adipose tissue. Both the diﬀerences for site and diet were stat-
istically significant. Combined WAT weight of control rats for
the four WAT sites was 8.1% of the body weight, compared
with 15.2% for cafeteria rats. The diﬀerence in the body weight
minus the sum of WAT sites was minimal for both the dietary
groups (213 g controls, 226 g cafeteria), suggesting that WAT
was, precisely, the main factor justifying the diﬀerences
observed in the body weight. The diﬀerences induced by diet
and those on WAT sites were also statistically significant for
the protein content and total RNA. However, both protein and
RNA tended to decrease in cafeteria rats when expressed per g
of tissue. The RNA/protein ratio decreased considerably in all
WAT sites fed the cafeteria diet; the mesenteric ratio showing
the highest, and subcutaneous WAT the lowest values.
Fig. 1 Comparison of the body weight of female rats fed control
or cafeteria diets. The data are the mean ± SEM of 6 diﬀerent animals.
Statistical signiﬁcance of the diﬀerences between groups (two-way
ANOVA). T represents the P value for “time” and D that for “diet”.
Table 2 WAT weight, protein and RNA content of female Wistar rats fed for 30 d with a cafeteria diet
Parameter Site Unit Control Cafeteria P diet P site
WAT weight SC g 7.02 ± 0.25 12.3 ± 0.3 <0.0001 <0.0001
ME 3.92 ± 0.33 9.02 ± 1.25
PO 4.83 ± 0.39 11.8 ± 1.7
RE 2.79 ± 0.35 7.81 ± 0.77
∑WAT g 18.6 ± 0.93 41.0 ± 3.5 0.0001 —
% BW 8.05 ± 0.52 15.2 ± 0.5 <0.0001 —
Protein SC mg g−1 51.8 ± 3.3 41.2 ± 4.3 0.0010 <0.0001
ME 84.2 ± 2.6 77.4 ± 5.8
PO 54.4 ± 2.4 47.6 ± 2.6
RE 62.9 ± 4.7 50.7 ± 1.3
RNA SC µg g−1 219 ± 19 154 ± 15 <0.0001 <0.0001
ME 793 ± 88 92.0 ± 5.5
PO 119 ± 10 57.6 ± 4.1
RE 78.4 ± 8.8 38.4 ± 6.2
RNA/protein ratio SC mg g−1 4.25 ± 0.13 4.77 ± 0.86 <0.0001 <0.0001
ME 9.49 ± 1.13 1.87 ± 0.68
PO 2.19 ± 0.16 1.24 ± 0.14
RE 1.26 ± 0.12 0.75 ± 0.11
The data are the mean ± SEM of 6 diﬀerent animals per group. Statistical significance of the diﬀerences between groups (two-way ANOVA: diet
and WAT site). BW = body weight. SC = subcutaneous WAT; ME = mesenteric WAT; PO = periovaric WAT; RE = retroperitoneal WAT. The sum of
these four sites is indicated as∑WAT.
Fig. 2 Comparison of the protein and RNA content of the four main WAT
sites of female rats fed control or cafeteria diets. The data are the mean ±
SEM of 6 diﬀerent animals. Lilac columns: control diet; soft red columns:
cafeteria diet. WAT sites: SC = subcutaneous, ME = mesenteric, PO = perio-
varic; RP = retroperitoneal. Statistical signiﬁcance of the diﬀerences between
groups (two-way ANOVA). S represents the P value for “site” and D that for
“diet”. Only signiﬁcant results have been shown. Individual site diﬀerences
(diet) are marked with an asterisk * (P < 0.05, post-hoc Tuckey’s test).
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Plasma parameters were all within the expected range and
were similar to previously published data.26,35 They are pre-
sented in ESI Table 1.†
Fig. 2 depicts the data in Table 1 but tissue protein and
RNA are presented as the total amount present in the whole
site for the direct comparison of the eventual changes induced
by the diet. There were overall significant diﬀerences of cafe-
teria vs. controls for protein, although they were not observed
in subcutaneous WAT, nor between sites. When analyzing
RNA, the diﬀerences were less patent; cafeteria diet-feeding
resulted in a marked overall diﬀerence between sites, but not
diet. In fact, the only site showing a marked diﬀerence
Fig. 3 Total activity and gene expression of urea cycle enzymes present in the mass of WAT tissue sites of female rats fed control or cafeteria diets.
The data are the mean ± SEM of 6 diﬀerent animals. Left, enzyme activities: blue dashed columns: control diet; red dashed columns: cafeteria diet.
Right, gene expressions: blue columns: control diet; red columns: cafeteria diet. WAT sites: SC = subcutaneous, ME = mesenteric, PO = periovaric;
RP = retroperitoneal. The expression data for arginase are the sum of Arg1 and Arg2 for subcutaneous WAT, and of Arg1 for all other sites. Statistical
signiﬁcance of the diﬀerences between groups (two-way ANOVA). S represents the P value for “site” and D that for “diet”. Only signiﬁcant results
have been shown. Individual site diﬀerences (diet) are marked with an asterisk * (P < 0.05, post-hoc Tuckey’s test).
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between the diet groups was mesenteric, in which the total
RNA content of the tissue was reduced to roughly one third
with cafeteria diet.
Fig. 3 shows the urea cycle enzyme activities present in the
whole site (nkat or µkat), and the expressions of the corres-
ponding genes (i.e. in nmol or µmol of the specific gene
mRNA), also expressed with respect to the whole site. The argi-
nase value for activity corresponds to the sum of arginases 1
and 2; the latter being expressed only in subcutaneous WAT.
The corresponding value for gene expression reflects also the
sum of Arg1 and Arg2. There was clear discordance between
the total enzyme activities and the mRNA content for their
coding genes in diﬀerent sites. In all the cases (activities and
expressions), there was a significant diﬀerence between the
Fig. 4 Total expression (i.e. speciﬁc mRNA content) of amino acid metabolism enzyme genes present in the mass of WAT tissue sites of female rats
fed control or cafeteria diets. The data are the mean ± SEM of 6 diﬀerent animals. Blue columns: control diet; red columns: cafeteria diet. WAT sites:
SC = subcutaneous, ME = mesenteric, PO = periovaric; RP = retroperitoneal. Statistical signiﬁcance of the diﬀerences between groups (two-way
ANOVA). S represents the P value for “site” and D that for “diet”. Only signiﬁcant results have been shown. Individual site diﬀerences (diet) are marked
with an asterisk * (P < 0.05, post-hoc Tuckey’s test).
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WAT sites. However, the overall eﬀects of diet were minimal,
significant only for ornithine carbamoyl-transferase activity
and the expressions of arginase and carbamoyl-P synthase. In
general, subcutaneous WAT showed higher activities for carb-
amoyl-P synthase 2, arginino-succinate lyase and arginase
activities (and expressions). Cafeteria diet induced a marked
increase in ornithine carbamoyl-transferase activity and
decrease in arginino-succinate synthase activity in mesenteric
WAT. This diet increased ornithine carbamoyl-transferase, argi-
nino-succinate lyase and the expressions of both arginases in
subcutaneous WAT; cafeteria feeding decreased the expression
of carbamoyl-P synthase in mesenteric WAT and arginino-
succinate synthase in periovaric WAT. In spite of punctual vari-
ations, and the marked diﬀerences between sites, the general
trend was to maintain the same amount of active enzyme and
specific gene mRNA in the WAT sites, with only limited
changes, despite their diﬀerent mass and dietary treatment.
Fig. 4 shows the expressions of gene coding for proteins
related to ammonia/2-amino N metabolism in four sites of
WAT in control or cafeteria diet-fed female rats. All genes
showed significant diﬀerences in expression between sites, but
the overall eﬀects of diet were limited to Glul, glutamine
synthetase; Glud1, NADP+ glutamate dehydrogenase; Gls, glut-
aminase; Gcsh, h protein of the glycine cleavage system; and
Bcat2, branched-chain amino acid aminotransferase (mito-
chondrial). In addition to these generalized modifications,
specific sites showed significant changes with cafeteria diet
feeding, i.e. increases in subcutaneous WAT for all genes
except Ala1 and Ala2. On the other side, mesenteric WAT also
showed significant decreases for Amp2, and Bcat1; Glul was
increased in periovaric WAT.
By comparison, Fig. 5 depicts the WAT site lactate dehydro-
genase activity (µkat in the whole tissue mass) and the corres-
ponding values for gene coding for both the lactate
dehydrogenases, a and b (Ldha, Ldhb). In addition to a signifi-
cant diﬀerence for site, both lactate dehydrogenase activity
and Ldha changed significantly with diet. Periovaric WAT
activity was higher in cafeteria diet-fed rats, whereas the
expression of Ldha and Ldhb were lower in subcutaneous WAT
under the hyperlipidic diet.
The data of Fig. 3–5 are also presented in the more usual
form of activity/expression per unit of protein weight in the
ESI, Tables 2–5.†
Discussion
Cafeteria diet is a widely used and robust model of metabolic
syndrome in rodents,36–38 characterized by voluntary hyper-
phagia and grossly elevated fat intake which results in rapid
weight gain. In addition, cafeteria diet feeding induces glucose
intolerance and inflammation in rodents.38 It has been found
that relatively short periods of exposure to a cafeteria diet are
enough to disturb the metabolic response to food availability
in key tissues, and hence alter energy homeostasis, particularly
in WAT. These changes often induce exacerbated body fat
accumulation and increased metabolic risk, often with no
apparent or minimal eﬀects on body weight.39 Thus, this
model provides a unique animal platform to study the bio-
chemical mechanisms that characterize obesity and the meta-
bolic syndrome. The main result derived from the present
study has been rather surprising, since, in spite of doubling
the size of WAT because of one month of eating an energy-rich
cafeteria diet, the actual transforming capacity of most amino
acid metabolism enzymes in WAT remained practically
Fig. 5 Total activity and expression of lactate dehydrogenase genes
present in the mass of WAT tissue sites of female rats fed control or
cafeteria diets. The data are the mean ± SEM of 6 diﬀerent animals.
Activity: blue dashed columns: control diet; red dashed columns: cafe-
teria diet. Expressions: blue columns: control diet; red columns: cafe-
teria diet. WAT sites: SC = subcutaneous, ME = mesenteric, PO =
periovaric; RP = retroperitoneal. Statistical signiﬁcance of the diﬀer-
ences between groups (two-way ANOVA). S represents the P value for
“site” and D that for “diet”. Only signiﬁcant results have been shown.
Individual site diﬀerences (diet) are marked with an asterisk * (P < 0.05,
post-hoc Tuckey’s test).
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unchanged with respect to the whole adipose tissue. This was
a consequence of only limited changes in the overall enzyme
activity, but also because of a generalized decrease in the
expression of the corresponding genes when related to tissue
weight. The considerable increase in the size of WAT was
mainly due to the accumulation of fat, but protein followed
suit. The most marked diﬀerences were in the RNA content,
which actually decreased in most sites, largely compensating
the disproportion in size.
The remarkable stability of urea cycle enzyme activities
observed here contrasts with the decreases observed in the
liver.21 However, one can wonder whether the actual impor-
tance of the changes in liver functions would be appreciated
as so deep if the activity/expression were corrected by the
actual size (and, better, including blood flow)13 of the organ.
The enormous change that WAT experiences when challenged
with an excess of nutrients, however, is not comparable to any
other “regular” organ. We speculated whether part of the pro-
blems derived from an enlarged (in fact engorged) WAT would
be a consequence of the disproportion of its mass with respect
to all other tissues; however, what we found experimentally
was a clear downregulation of enzyme activities that practically
compensated the increase in tissue mass.
Lowered blood flow40 may be – also – part of the homoeo-
static adjustment to increased WAT mass, since lower relative
blood flow is consistent with decreased metabolic activity
(according to the low total RNA data). In addition, excess
“inert” triacylglycerol stores reduce considerably the active
tissue mass. In any case, the maintenance of most enzyme
activities/gene expressions seems to be a consequence of a gen-
eralized homoeostatic adjustment preventing the eventual loss
of balance between organ (size) and function. We are aware
that the form of expression we used here must be complemen-
ted with other, more common, forms of data representation
(presented in the ESI Tables 2–5†). The results obtained made
us suggest that the analysis we carried out on key aspects of
amino acid metabolism should be applied to the most critical
aspects of glucose handling and lipogenesis too, to check
whether the increased WAT size is countered by a generalized
diminution of its metabolic activity. Our own data suggest that
diet has only a limited (if any) eﬀect on lactate metabolism
in vivo.13 The results presented here corroborate the conclusions
obtained from tissue lactate levels and enzyme activities.13
Lactate dehydrogenase (and lactate metabolism) is diminished
in adipocytes of obese animals,13,41 but the overall handling
capacity is maintained as we have shown here.
The results presented highlight a diﬀerential role for sub-
cutaneous WAT, at least for amino acid metabolism, since its
cumulative activity for most enzymes was higher than the com-
bined activities of the other three sites studied. The widely
known metabolic diﬀerence between subcutaneous and “visc-
eral” WAT,42,43 in this case represented by the mesenteric site,
was in part confirmed by a loss of amino acid metabolizing
activity in this site in rats fed a cafeteria diet; this eﬀect was
largely compensated by an increase in subcutaneous WAT
activity. This shift of function from the splanchnic bed to peri-
pheral tissues agrees with the loss of energy substrate control
of the liver in obesity.44,45 It is also in agreement with the
predominant role of peripheral tissues as suppliers of sub-
strates under starvation: muscle exports 3C units,46 and WAT
fatty acids47 (and 3C units too14) after the liver exhausted its
glycogen reserves and when the intestine cannot supply
dietary-derived nutrients.48 It has been postulated that a high
availability of circulating fatty acids spurns insulin resistance
as a way to save glucose, and this eﬀort is counterproductive
when the fatty acids come from the diet (i.e. together with
glucose) and not from peripheral lipolysis.49 Under these
overfeeding conditions, thus, the problem of disposing of
excess glucose becomes a priority. Moreover, since 2-amino N
preservation is critical for survival (an evolutionary fiat),19
consequently, amino acids become even more diﬃcult to
dispose of through the well-controlled splanchnic catabolic
pathways.50
The lowered amino acid disposal capacity observed in cafe-
teria-diet fed rats21,37 stems from a lowered or unfocussed
function of the liver (in fact liver-intestine as a unit), and is
reflected in lower levels and excretion of urea.21,37 We wanted
to check whether the newly found WAT urea cycle could
somehow compensate the disorder caused in the liver by meta-
bolic syndrome, perhaps through the activation of peripheral
amino acid catabolism. The surprising lack of change in the
peripheral urea cycle suggests a maintenance of its function in
spite of lowered activity/gene expression per g of tissue. Since
the combined activity of WAT in both dietary groups was
higher for a number of enzyme activities than in the liver,51 we
must assume that, at least in part, the production of urea may
be taken up by WAT in the obese. The peculiar increase in
enzyme activities observed in subcutaneous WAT suggests that
this site (the most “peripheral” of those studied here) may play
a role more important than usually assumed in amino acid
handling. High Nags expression may indicate an activation of
the synthesis of ornithine,52 in agreement with the role of WAT
as a postulated peripheral producer of citrulline.53 This
increase may help compensate the alteration of citrulline syn-
thesis by the intestine54 in obesity.
Glul increased expression in subcutaneous WAT of rats fed
a cafeteria diet, suggests that part of the ammonium probably
produced by the increased expression of Amp2 and the glycine
cleavage system, but also Gls (to a lower extent), is not driven
towards the urea cycle, but maintained as glutamine or glut-
amate (increased expression of Glud1). However, there is a clear
role of subcutaneous WAT in the catabolism of 2-amino N as
clearly shown by the considerable increases in the expression
of Bcat1 and Bcat2, marking this site as a probably significant
place for the catabolism of branched-chain amino acids, as
previously suggested.55 This contrasts with the lack of changes
in Gpt and Gpt2, in spite of the known release of alanine by
adipocytes.56
We can summarize our findings by stating that increased
WAT mass produced by cafeteria diet feeding does not trans-
late into higher overall WAT metabolic activity, but to its main-
tenance: the enzyme activities and RNA are diluted in a
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reversed proportion to the increase in mass of the tissue. This
is logical from a homoeostatic point of view, since, under this
assumption, the only significant diﬀerence in the WAT func-
tion from lean to obese would be the storage of fat. This ques-
tion needs further metabolic analyses to check whether lipid
metabolism follows the same trend, and, further, to determine
the diﬀerences between the initial phases of WAT engorgement
and a relative steady state as that observed here.
The other key point is the remarkable constancy of the WAT
urea cycle under high energy availability, under the pressure of
excess 2-amino N availability and the need to dispose of it
against the powerful mechanisms of preservation of amino
acids. The only clear trend observed was the shift in amino
acid metabolism from abdominal WAT, mainly mesenteric, to
an acquired metabolic predominance of subcutaneous WAT, in
line with the displacement of metabolic activity from the
splanchnic bed to peripheral tissues typical of starvation and,
contrastingly, of the excess of nutrient availability.
Overall, the results of this study give support to the con-
sideration of WAT as an organ,57 disperse58 but under uniform
control.35 The metabolic peculiarities between its diﬀerent
sites,59–61 and their ability to adapt to diﬀerent energy avail-
ability conditions only add to the protean nature of the
adipose tissue. Last, but not least, we have presented
additional evidence on the role of WAT in amino acid metab-
olism, a question diﬃcult to discuss because of the absence of
suﬃcient studies with which we can compare and check our
results.
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